Counts describe this library, not the strength of evidence.
How to read this evidence
Separate prevention outcomes, risk-factor changes and screening performance. A drug trial in established disease, an exercise blood-pressure analysis and a smartwatch alert study cannot be treated as equivalent evidence for a healthy individual.
Pooling 12 trials in 878 adults with heart disease or hypertension, higher fibre intake lowered systolic blood pressure by 4.3 mmHg and diastolic by 3.1 mmHg in people with hypertension; in 3 cohorts of 7469 adults with heart disease, higher fibre intake was linked to lower all-cause mortality (RR 0.75). The mortality finding is observational and based on only three studies, and several other outcomes were rated low certainty.
Among 30,434 US adults in NHANES 2005-2018, trouble sleeping (OR 1.359) and depression (OR 1.276) were each linked to hypertension, and having both went beyond the sum of the two (RERI 0.528, 95% CI 0.182-0.873). This is a one-time cross-sectional snapshot, so it cannot show which came first or that treating either lowers blood pressure.
In 434 adults with elevated clinic readings, 5 days of home blood pressure monitoring differed from daytime 24-hour monitoring by -0.1 mm Hg in systolic pressure (95% CI -1.6 to 1.5), while clinic readings were 4.7 mm Hg lower and kiosk readings 9.5 mm Hg higher. Participants came from one health care organization and were mostly white.
In 45 boys with obesity aged 10 to 13, 12 weeks of school running intervals raised aerobic fitness more than steady moderate running (6.1 vs 3.8 mL/kg/min, P < 0.01) and lowered BMI and fat mass. Only 15 boys were in each group, so these results need confirmation in a larger, multi-school trial.
In Taiwan's national insurance database, adding hypertension to type 2 diabetes was associated with more coronary artery disease (HR 2.22, 95% CI 2.07 to 2.37) and stroke (HR 1.19), and adding diabetes to hypertension with more coronary disease (HR 1.69). Heart failure risk did not differ in any comparison. This is claims-based cohort data, so diagnosis timing and lifestyle factors may be imperfectly captured.
Using genetic variants as proxies in 16 144 people with advanced age-related macular degeneration (AMD) and 17 832 controls, genetically predicted smoking was linked to higher risk of advanced AMD (OR 1.26 for smoking initiation) and alcohol to higher risk of geographic atrophy (OR 2.70). Mendelian randomization reduces confounding but depends on assumptions, and the alcohol estimate is very uncertain (95% CI 1.48-4.94).
Among 7511 male workers without hypertension followed for 8 years, drinking 154 g ethanol a week was linked to higher odds of new hypertension than abstaining (adjusted OR 1.51, 95% CI 1.27-1.79 in nonsmokers; 1.81, 1.54-2.11 in smokers). Men only, and no absolute risks reported, so the real-world size of the effect is unclear.
International journal of environmental research and public health
Across 19 randomised trials with 145 939 participants, lowering systolic blood pressure by 5 mm Hg reduced new-onset type 2 diabetes by 11% (HR 0.89, 95% CI 0.84-0.95), though drug classes differed: ACE inhibitors and ARBs lowered risk, while beta blockers and thiazide diuretics raised it. The trials were run between 1973 and 2008 and were not designed to test diabetes prevention, so diabetes was not the original main endpoint.
In 2962 Framingham Study participants followed for a mean of 15 years, high midlife estimated fitness was linked to lower risk of hypertension (HR 0.63), diabetes (HR 0.38) and cardiovascular disease (HR 0.71). But estimated fitness is a formula score using age, BMI, waist, activity, resting heart rate and smoking, so it cannot isolate fitness itself.
In a cross-sectional analysis of Iranian adults aged 35-70, higher adherence to a DASH-style diet went with 19% lower odds of high total cholesterol (OR 0.81, 95% CI 0.69-0.95) and 18% lower odds of a high LDL/HDL ratio (OR 0.82, 0.70-0.96). One snapshot in time cannot show the diet caused better lipids.
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
In pooled data from 51 trials and 358,707 participants, each 5 mm Hg drop in systolic blood pressure lowered the hazard of major cardiovascular events by about 9% in people aged 55 to 84 (HR 0.91), with no clear benefit in those 85 and older (HR 0.99, 95% CI 0.87-1.12). Only 4788 participants were 85 or older, so the oldest group is the least certain.
Among 66,692 Korean adults with newly diagnosed atrial fibrillation, those who exercised both before and after diagnosis had lower mortality (HR 0.61, 95% CI 0.55-0.67) and heart failure risk (HR 0.92, 95% CI 0.88-0.96) than people who never exercised. Exercise was self-reported on questionnaires, so recall bias and unmeasured differences may remain.
In the DiRECT diet-replacement arm, 65 of 78 people treated for hypertension stopped all blood pressure medicines per protocol and mean blood pressure fell, yet 19 of the 69 who stopped had medicines restarted. This is a post hoc analysis of one trial arm with no comparison group, run under close monitoring.
In 86 healthcare workers given two doses of the Pfizer/BioNTech vaccine, larger waist circumference (R = -0.324, p = 0.004), smoking, hypertension and longer time since the second dose were associated with lower antibody titres. The sample was small and antibody level is only a surrogate for protection.
In a 6-week randomised trial of 48 healthy older adults (mean age 71), both high-intensity interval cycling and isometric handgrip training lowered resting systolic blood pressure by 9 mmHg, while remote ischaemic preconditioning and no intervention did not. The trial is small, tested healthy volunteers in supervised sessions, and the abstract gives no confidence intervals or group sizes.
Across 48 randomised trials with 344,716 participants, lowering systolic blood pressure by 5 mm Hg with medication cut the hazard of a major cardiovascular event (HR 0.91 without prior cardiovascular disease, 0.89 with it), including at normal or high-normal starting pressures. The trials were published between 1972 and 2013 with a median follow-up of 4.15 years, so long-term and modern-practice effects are not addressed.
In national survey data on 19 273 US children and adolescents, average blood pressure fell between 1999-2002 and 2011-2014 and then rose in 2015-2018, for example diastolic pressure in children aged 8 to 12 from 51.9 to 53.2 mm Hg. These are repeated cross-sectional snapshots of different children, and the recent rise is small enough that the authors say only that levels "may have increased".